[When the legs have to keep moving at night--the restless legs syndrome]
- PMID: 17724966
[When the legs have to keep moving at night--the restless legs syndrome]
Abstract
The restless legs syndrome (RLS) is a frequently occurring neurological disease that is often associated with sleep disorders and reduced quality of life. The cause of RLS still has not been clearly established; however, the dopaminergic and opioid systems and iron metabolism appear to have major roles in the disease. The therapy of choice is treatment with dopaminergic drugs. In addition, opiates and anticonvulsants such as gabapentin are used. The most important side effect of dopaminergic therapy is augmentation. If therapy-related augmentation occurs while taking levodopa, the medication should be changed to dopamine agonists. If augmentation occurs while taking dopamine agonists, opiates or gabapentin should be taken instead.
Similar articles
-
Restless legs syndrome: nonpharmacologic and pharmacologic treatments.Geriatrics. 2007 Oct;62(10):13-6. Geriatrics. 2007. PMID: 17922563 Review.
-
Restless legs syndrome: pathophysiology and modern management.Postgrad Med J. 2013 Jul;89(1053):402-10. doi: 10.1136/postgradmedj-2012-131634. Epub 2013 Mar 22. Postgrad Med J. 2013. PMID: 23524988 Review.
-
Restless legs syndrome: clinical presentation diagnosis and treatment.Sleep Med. 2015 Jun;16(6):678-90. doi: 10.1016/j.sleep.2015.03.002. Epub 2015 Mar 10. Sleep Med. 2015. PMID: 25979181 Review.
-
Latest guidelines and advances for treatment of restless legs syndrome.J Clin Psychiatry. 2014 Apr;75(4):e08. doi: 10.4088/JCP.12074nr3c. J Clin Psychiatry. 2014. PMID: 24813409 Review.
-
Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.Ren Fail. 2004 Jul;26(4):393-7. doi: 10.1081/jdi-120039823. Ren Fail. 2004. PMID: 15462107 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical